Covid-19 Tracker for Global Vaccines – The New York Times

More than 131,500,000 doses of vaccines have been administered worldwide, equivalent to 1.7 doses for every 100 people. There is already a clear gap between vaccination programs in different countries, and most still need to report a single dose.

The data is compiled from government sources through the Our World in Data project at the University of Oxford. A vaccinated person refers to someone who has received at least one dose of vaccine, and a fully vaccinated person received all required doses of a vaccine. For the Pfizer-BioNTech vaccine, a person who was ‘fully vaccinated’ received two doses.

While the vaccine dose worldwide is relatively scarce, most countries have focused their early vaccination efforts on priority groups such as the clinically vulnerable; people in their 60s, 70s and older; and frontline workers, such as doctors and nurses. Israel is vaccinating its population faster than any other country, with 62.6 doses administered for every 100 people.

Following the record-breaking development of coronavirus vaccines, initial vaccination rates have become a controversial issue for many countries.

The European Union has slowly begun its vaccination campaign, with regulatory approval against Pfizer-BioNTech and Moderna. European countries are currently lagging behind the United States as well as the United Kingdom by a significant margin. The United Kingdom gave 18.8 doses per 100 people, while the Netherlands, Austria and France still had to administer four doses per 100 people.

There is also a striking gap between continents. North America has already administered 7.3 doses per 100 people, while vaccinations have just begun in Africa. Morocco and Algeria were the first African countries to start vaccinations.

Less prosperous countries are relying on an arrangement for the part of vaccines called Covax, which aims to deliver two billion doses by the end of the year. Australia, which has had fewer than 1,000 coronavirus deaths, has approved the Pfizer-BioNTech vaccine, but the first doses are not expected until late February.

It is administered according to eight different vaccines around the world Our world in data. The Pfizer BioNTech vaccine, which is 95 percent effective in reducing coronavirus infections, is currently being used in 57 countries. Several countries have approved vaccines, but have yet to begin administrations.

All of the vaccines currently in use require two doses for a patient to be fully vaccinated, although a one-vaccine vaccine by pharmaceutical giant Johnson & Johnson is expected to be approved in the United States within a few weeks.

Tracking the Coronavirus